[{"Assets_0_Q2_USD":105892000.0,"CommonStockSharesOutstanding_0_Q2_shares":25775056.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-17300000.0,"NetIncomeLoss_1_Q2_USD":-10007000.0,"NetIncomeLoss_2_Q2_USD":-21348000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":25773879.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":25763858.0,"StockholdersEquity_0_Q2_USD":82787000.0,"Ticker":"XENE","CIK":"1582313","name":"XENON PHARMACEUTICALS INC.","OfficialName":"Xenon Pharmaceuticals Inc. Common Shares","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1764405075.0","Country":"Canada","Sector":"nan","Industry":"nan","Market":"NASDAQ","SP500":"nan","filed":"20190806"}]